scispace - formally typeset
J

Julie St-Pierre

Researcher at University of Ottawa

Publications -  81
Citations -  9398

Julie St-Pierre is an academic researcher from University of Ottawa. The author has contributed to research in topics: Mitochondrion & Cancer. The author has an hindex of 36, co-authored 70 publications receiving 7575 citations. Previous affiliations of Julie St-Pierre include McGill University.

Papers
More filters
Journal ArticleDOI

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α

TL;DR: The data indicate that AMPK phosphorylation of PGC-1α initiates many of the important gene regulatory functions of AMPK in skeletal muscle.
Journal ArticleDOI

mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation

TL;DR: It is demonstrated that mTORC1 controls mitochondrial activity and biogenesis by selectively promoting translation of nucleus-encoded mitochondria-related mRNAs via inhibition of the eukaryotic translation initiation factor 4E (eIF4E)-binding proteins (4E-BPs).
Journal ArticleDOI

PGC1α and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders.

TL;DR: How the biogenesis and remodelling of mitochondria that are elicited by PGC1&agr; contribute to an increase in oxidative metabolism and the preservation of ROS homeostasis is discussed and the importance in ageing and neurodegenerative disorders is examined.
Journal ArticleDOI

A roadmap for interpreting 13 C metabolite labeling patterns from cells

TL;DR: Key issues in interpreting (13)C metabolite labeling patterns are reviewed, with the goal of drawing accurate conclusions from steady state and dynamic stable isotopic tracer experiments.
Journal ArticleDOI

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

TL;DR: It is demonstrated that PDK1 is required for efficient liver metastasis, and its expression is elevated in liver metastases from breast cancer patients, and the data implicatePDK1 as a key regulator of metabolism and metastatic potential in breast cancer.